Please disregard from exchange notice (26/16) regarding additional dividend in Novo Nordisk A/S (Novo Nordisk) published on February 26, 2016.
The board of Novo Nordisk proposed, in a press release published on February 3, 2016, a dividend scheduled for August 2016. In the previously announced exchange notice (26/16) the dividend was specified as an additional dividend. NASDAQ Derivatives Markets has decided to treat this as an ordinary dividend. No re-calculation of options or futures in Novo Nordisk (NOVOB) will be made as a result of this dividend.
For further information please see the attached file.
